Article Versions Notes

Alsfouk AA, Alshibl HM, Altwaijry NA, Alanazi A, AlKamaly O, Sultan A, Alsfouk BA. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals. 2023; 16(7):1018. https://doi.org/10.3390/ph16071018

Alsfouk, Aisha A., Hanan M. Alshibl, Najla A. Altwaijry, Ashwag Alanazi, Omkulthom AlKamaly, Ahlam Sultan, and Bshra A. Alsfouk. 2023. "New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches" Pharmaceuticals 16, no. 7: 1018. https://doi.org/10.3390/ph16071018

Alsfouk, A. A., Alshibl, H. M., Altwaijry, N. A., Alanazi, A., AlKamaly, O., Sultan, A., & Alsfouk, B. A. (2023). New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals, 16(7), 1018. https://doi.org/10.3390/ph16071018